Meyka Pro banner
Artivion, Inc.

Artivion, Inc. Fundamental Analysis (NYSE: AORT)

AORT●NYSE
HealthcareMedical - Devices
$20.64
$0.43(2.13%)
U.S. Market opens in 15h 50m

Artivion, Inc. Fundamental Analysis (NYSE: AORT)

Artivion, Inc. (NYSE: AORT) shows moderate financial fundamentals with a PE ratio of -56.76, profit margin of -3.65%, and ROE of -3.93%. The company generates $0.5B in annual revenue with strong year-over-year growth of 13.59%.

Key Strengths

PEG Ratio-0.24
Current Ratio4.42

Areas of Concern

ROE-3.93%
Operating Margin1.92%
Cash Position4.82%
We analyze AORT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 26.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
26.4/100

We analyze AORT's fundamental strength across five key dimensions:

Efficiency Score

Weak

AORT struggles to generate sufficient returns from assets.

ROA > 10%
-1.69%

Valuation Score

Excellent

AORT trades at attractive valuation levels.

PE < 25
-56.76
PEG Ratio < 2
-0.24

Growth Score

Moderate

AORT shows steady but slowing expansion.

Revenue Growth > 5%
13.59%
EPS Growth > 10%
1.69%

Financial Health Score

Excellent

AORT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.91
Current Ratio > 1
4.42

Profitability Score

Weak

AORT struggles to sustain strong margins.

ROE > 15%
-392.99%
Net Margin ≥ 15%
-3.65%
Positive Free Cash Flow
No

Key Financial Metrics

Is AORT Expensive or Cheap?

P/E Ratio

AORT trades at -56.76 times earnings. This suggests potential undervaluation.

-56.76

PEG Ratio

When adjusting for growth, AORT's PEG of -0.24 indicates potential undervaluation.

-0.24

Price to Book

The market values Artivion, Inc. at 2.23 times its book value. This may indicate undervaluation.

2.23

EV/EBITDA

Enterprise value stands at 15.11 times EBITDA. This signals the market has high growth expectations.

15.11

How Well Does AORT Make Money?

Net Profit Margin

For every $100 in sales, Artivion, Inc. keeps $-3.65 as profit after all expenses.

-3.65%

Operating Margin

Core operations generate 1.92 in profit for every $100 in revenue, before interest and taxes.

1.92%

ROE

Management delivers $-3.93 in profit for every $100 of shareholder equity.

-3.93%

ROA

Artivion, Inc. generates $-1.69 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.69%

Following the Money - Real Cash Generation

Operating Cash Flow

Artivion, Inc. generates limited operating cash flow of $14.90M, signaling weaker underlying cash strength.

$14.90M

Free Cash Flow

Artivion, Inc. generates weak or negative free cash flow of $-44.41M, restricting financial flexibility.

$-44.41M

FCF Per Share

Each share generates $-0.91 in free cash annually.

$-0.91

FCF Yield

AORT converts -4.53% of its market value into free cash.

-4.53%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-56.76

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.24

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.23

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.07

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.91

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.42

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.04

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

0.010

vs 25 benchmark

How AORT Stacks Against Its Sector Peers

MetricAORT ValueSector AveragePerformance
P/E Ratio-56.7630.84 Better (Cheaper)
ROE-3.93%573.00% Weak
Net Margin-3.65%5349.00% Weak
Debt/Equity0.91-0.03 (disorted) Distorted
Current Ratio4.425.76 Strong Liquidity
ROA-1.69%-254.00% (disorted) Weak

AORT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Artivion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

45.55%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

148.90%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

157.45%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ